SCHEMBL17599429

SCHEMBL17599429

Cc1cc(C)c(C)c(S(=O)(=O)Nc2cc(-c3cc(Cl)cc(C(=O)O)c3)cc3ccccc23)c1C

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ CRHBP P24387 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ PTGER4 P35408 2/20 0.42
▸ PTGER2 P43116 1/20 0.42
▸ ACLY P53396 7/20 0.41
▸ KEAP1 Q14145 3/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ FABP4 P15090 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599466 0.88 KMT2A (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599510 0.88 KMT2A (0.53) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599467 0.87 KMT2A (0.55) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599433 0.85 KMT2A (0.48) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599431 0.85 KMT2A (0.50) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599483 0.83 MEN1 (0.56) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599423 0.81 ALDH1A1 (0.56) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599435 0.80 ALDH1A1 (0.57) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599460 0.78 HPGD (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599463 0.76 ALDH1A1 (0.57) KMT2AMEN1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback